With nearly half of patients discontinuing semaglutide within 12 months — especially younger adults — clinicians face a growing challenge in sustaining long-term treatment. Medscape Medical News
Medscape10 Sept
Elevated markers of liver fat, fibrosis, and functional decline are associated with an increased risk for cardiovascular disease in people without clinical liver disease at baseline. Medscape Medical News
Medscape10 Sept
Patients with nonconvulsive status epilepticus treated with therapeutic coma experience markedly higher rates of complications and mortality than those not receiving the treatment. Medscape Medical News
Medscape10 Sept
Patients with obstructive sleep apnea who live in disadvantaged neighborhoods experience more severe sleep-related hypoxemia and have a higher risk for cardiovascular events. Medscape Medical News
Medscape10 SeptThe current agreement manufacturer Merck has signed for global access to its once-monthly alimatravir would exclude countries with more than 230,000 new HIV acquisitions a year. Medscape Medical News
Medscape10 Sept